Watson biology: the net profit in 2021 is expected to decrease by 54% - 64% year-on-year
Watson biology announced that in 2021, the company's pre profit was 365 million yuan – 460 million yuan, a year-on-year decrease of 54% - 64%. The company increased its R & D investment in new products and projects, actively promoted domestic and foreign clinical trials of key R & D projects, and the R & D expenses increased by about 256% over the same period of last year.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Discretionary, Consumer Staples, Financials
Is the U.S. TikTok the biggest opportunity for going global in 2024?
TikTok, a short-video social platform under ByteDance, made its debut in May 2017 and has since become a global phenomenon with over 1 billion active users worldwide.
Jan 16, 2024 06:05 AM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Apr 23, 2024 02:21 PM